| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and …
Over the last 12 months, insiders at GeoVax Labs, Inc. have bought $0 and sold $0 worth of GeoVax Labs, Inc. stock.
On average, over the past 5 years, insiders at GeoVax Labs, Inc. have bought $43,299 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,107 shares for transaction amount of $742 was made by McKee Kelly T. Jr. (Chief Medical Officer) on 2025‑08‑07.
| 2025-08-07 | McKee Kelly T. Jr. | Chief Medical Officer | 1,107 0.0044% | $0.67 | $742 | -83.57% | ||
| 2025-04-10 | SPENCER JOHN N JR | director | 10,000 0.0744% | $0.98 | $9,800 | -40.45% | ||
| 2025-04-10 | Sharkey John W. | VP, Business Development | 6,000 0.0451% | $0.99 | $5,940 | -40.45% | ||
| 2025-04-01 | DODD DAVID A | President, CEO | 10,000 0.0723% | $1.08 | $10,800 | -46.04% | ||
| 2025-03-31 | Reynolds Mark | CFO | 6,800 0.0501% | $1.08 | $7,343 | -43.70% | ||
| 2024-08-09 | DODD DAVID A | President, CEO | 8,000 0.1589% | $1.95 | $15,600 | -6.71% | ||
| 2024-02-22 | DODD DAVID A | President, CEO | 8,209 0.431% | $2.27 | $18,663 | -3.42% | ||
| 2024-02-21 | DODD DAVID A | President, CEO | 520 0.0257% | $2.15 | $1,118 | -3.64% | ||
| 2024-02-07 | Reynolds Mark | CFO | 2,000 0.0718% | $2.77 | $5,540 | -15.89% | ||
| 2023-12-22 | McKee Kelly T. Jr. | Chief Medical Officer | 6,944 0.0257% | $0.36 | $2,500 | -58.08% | ||
| 2023-09-25 | McKee Kelly T. Jr. | Chief Medical Officer | 9,653 0.0371% | $0.52 | $5,020 | -63.44% | ||
| 2023-08-25 | DODD DAVID A | President, CEO | 35,087 0.1351% | $0.57 | $20,000 | -64.71% | ||
| 2023-08-18 | Reynolds Mark | CFO | 10,000 0.038% | $0.52 | $5,179 | -61.63% | ||
| 2023-04-24 | DODD DAVID A | President, CEO | 32,000 0.122% | $0.64 | $20,445 | -18.39% | ||
| 2023-04-20 | Reynolds Mark | CFO | 8,000 0.0297% | $0.63 | $5,040 | -19.14% | ||
| 2022-09-21 | CHASE RANDAL D | director | 10,000 0.043% | $1.10 | $11,000 | -39.45% | ||
| 2022-07-01 | Sharkey John W. | VP, Business Development | 1,000 0.0043% | $0.82 | $820 | -6.46% | ||
| 2022-06-27 | McKee Kelly T. Jr. | Chief Medical Officer | 4,464 0.0367% | $1.12 | $5,000 | -28.65% | ||
| 2022-06-21 | CHASE RANDAL D | 10,000 0.0761% | $1.21 | $12,100 | -38.29% | |||
| 2022-05-05 | McKee Kelly T. Jr. | Chief Medical Officer | 9,722 0.0758% | $0.72 | $7,000 | +11.57% |
| ROBINSON HARRIET L | CSO Emeritus | 1201226 11.8899% | $197,121.19 | 5 | 8 | |
| Tsolinas Peter M | director | 431734 4.2734% | $70,847.55 | 1 | 0 | |
| DODD DAVID A | President, CEO | 36661 0.3629% | $6,016.07 | 10 | 0 | <0.0001% |
| CHASE RANDAL D | director | 36613 0.3624% | $6,008.19 | 2 | 0 | <0.0001% |
| HILDEBRAND DONALD G | director | 19000 0.1881% | $3,117.90 | 1 | 0 | |
| Reynolds Mark | CFO | 14013 0.1387% | $2,299.53 | 10 | 0 | <0.0001% |
| SPENCER JOHN N JR | director | 11402 0.1129% | $1,871.07 | 5 | 0 | <0.0001% |
| MCNALLY ROBERT T | director | 8300 0.0822% | $1,362.03 | 7 | 0 | |
| Sharkey John W. | VP, Business Development | 6191 0.0613% | $1,015.94 | 2 | 0 | <0.0001% |
| McKee Kelly T. Jr. | Chief Medical Officer | 3494 0.0346% | $573.37 | 6 | 0 | <0.0001% |
| NEWMAN MARK J | Chief Scientific Officer | 3000 0.0297% | $492.30 | 1 | 0 |
$6,974,678 | 45 | -14.98% | $4.63M | |
$633,070 | 27 | -5.89% | $2.04M | |
$8,249,886 | 17 | -47.87% | $399,787.00 | |
GeoVax Labs, Inc. (GOVX) | $117,515 | 16 | -27.38% | $1.66M |
$24,098 | 12 | -21.64% | $1.44M |
| Increased Positions | 9 | +39.13% | 90,710 | +116.72% |
| Decreased Positions | 8 | -34.78% | 53,877 | -69.32% |
| New Positions | 6 | New | 83,387 | New |
| Sold Out Positions | 5 | Sold Out | 52,844 | Sold Out |
| Total Postitions | 24 | +4.35% | 114,551 | +47.39% |
| Sabby Management, Llc | $137.00 | 1.54% | 661,376 | +661,376 | New | 2025-09-30 |
| Armistice Capital, Llc | $111.00 | 1.24% | 533,897 | +533,897 | New | 2025-09-30 |
| Vanguard Group Inc | $51.00 | 0.57% | 244,163 | +129,007 | +112.03% | 2025-09-30 |
| Geode Capital Management, Llc | $43.00 | 0.48% | 207,074 | +100,119 | +93.61% | 2025-09-30 |
| Hudson Bay Capital Management Lp | $21.00 | 0.23% | 100,000 | +100,000 | New | 2025-09-30 |
| Ubs Group Ag | $12.00 | 0.14% | 58,428 | -141,829 | -70.82% | 2025-09-30 |
| Blackrock, Inc. | $6.00 | 0.06% | 27,565 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $5.00 | 0.06% | 25,120 | -25,000 | -49.88% | 2025-09-30 |
| Moneta Group Investment Advisors Llc | $4.00 | 0.05% | 20,000 | +10,000 | New | 2025-09-30 |
| State Street Corp | $3.00 | 0.04% | 16,828 | 0 | 0% | 2025-09-30 |